It has been reported that the expression of THBS2 is down-regulated in most GC patients, and the higher the expression of THBS2, the better the prognosis of GC patients, but the sample size was too small, only 14 cases (Sun et al., 2014). The gene discussed is THBS2; the disease is gastric cancer.